Brief: Noxopharm Announces Darrt-2 Clinical Trial In U.S.
Nov 9 (Reuters) - Noxopharm Ltd NOX.AX :
* NOXOPHARM ANNOUNCES DARRT-2 CLINICAL TRIAL IN U.S.
Source text for Eikon: ID:nBwSgTnYa
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer